CVS HEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
CVS Health (CVS) cuts full-year profit outlook
February 7, 2024 6:44 AM ESTCVS Health (NYSE: CVS) unveiled financial results for the fourth quarter and reduced its earnings outlook for 2024.
The stock initially fell in premarket trading before bouncing back into the green.
For FQ4 2023, the company reported earnings per share (EPS) of $2.12, topping the consensus... More
CVS Health (CVS) Tops Q4 EPS by 14c; Trims Outlook
February 7, 2024 6:33 AM ESTCVS Health (NYSE: CVS) reported Q4 EPS of $2.12, $0.14 better than the analyst estimate of $1.98. Revenue for the quarter came in at $93.81 billion versus the consensus estimate of $90.25 billion.
GUIDANCE:
CVS Health sees FY2024 EPS of at least $8.30, versus... More



